Diabetic Continuous Glucose Monitoring Study

If you are a type I or Type II diabetic, you may be eligible to participate in a Continuous Glucose Monitoring (CGM) study. The study is NOT intended to change your Diabetes treatment.  It is seeking to continue the development of an experimental CGM system.  You will be asked to wear a CGM for about 17 days with frequent self- glucose monitoring (supplies provided). The results of the CGM will later be compared to your self- glucose monitoring. There are 4 planned office visits and a follow phone call.

Please fill out our form below.

Our team will be in touch with you as soon as possible to discuss the study.

This field is for validation purposes and should be left unchanged.
Name(Required)
Is it OK if we text you?*(Required)
Your subscriber information is collected for the sole purpose of sending you messages related to the program content. Your subscriber information will not be sold, rented, or otherwise shared except where applicable by law. SMS Terms and Conditions: By entering your mobile number, you agree to receive promotional or informational text messages to the number you provide. Msg and data rates may apply; Msg frequency varies. Reply STOP to cancel. Contact support at (615) 329-2222 or info@clinicalresearchassociates.com
MM slash DD slash YYYY
Have You Been Diagnosed With Diabetes Type I or Type II?
Please select which medicine(s) you take for diabetes
Read About Why We Need To Know In the Description Above
How would you describe yourself?*
*Please check all that apply.

Want to Learn More about Weight Loss & Clinical Trials?

Read posts in our blog:

  1. Weight loss drug clinical trial underway in Nashville
  2. Humanism and empathy improve health care outcomes for underserved communities
  3. Why are patients paid for clinical trials?